JORDAN ERICA enters REVANCE THERAPEUTICS, INC. with 117.26K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/29/2024ACC: 0001479290-24-000045
Officer· Chief Commercial Officer
Since Feb 2024
117.26K
Baseline shares
100% direct
117.26K
Direct ownership
1 position
120K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned117.26K
Total
117.26K direct117.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 117.26K | Direct |
| Total | 117.26K | 117.26K direct |
Derivative Holdings1
Performance Stock Units
DirectUnderlying security
Common Stock
Underlying shares
120K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
120K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock | 0 | — | — | 120K | N/A |
| Total | 120K | 0.00 | ||||